Basic Information
RNALocate ID: | RLID:11000623 |
RNA Symbol: | hsa-let-7d-5p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-let-7d |
RNA ID: | miRBase:MIMAT0000065 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001219 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001220 | Cytoplasm | Colon cancer cells | 20864815 |
RLID:01001221 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001222 | Cytoplasm | HeLa cells | 22058130 |
RLID:01001223 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001224 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001225 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001226 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001227 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001228 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001229 | Nucleus | HeLa cells | 22058130 |
RLID:11000611 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
RLID:11000612 | Exosome | Human cervical carcinoma cell line (SiHa) | 25760330 |
RLID:11000613 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
RLID:11000614 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11000615 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11000616 | Exosome | Breast milk | 22211110 |
RLID:11000617 | Exosome | Epidermal melanocytes (HEMa-LP) | 23056502 |
RLID:11000618 | Exosome | Brain tissue | 23382797 |
RLID:11000619 | Exosome | Plasma | 23663360 |
RLID:11000620 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11000621 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
RLID:11000622 | Microvesicle | Plasma | 23077538 |
RLID:11000624 | Microvesicle | Follicular fluid | 23666971 |
RLID:11000625 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000004 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000264 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-let-7d-5p | Diffuse large b cell lymphoma | MNDR-E-MI-01210 |
MNDR | hsa-let-7d-5p | Splenic marginal zone lymphoma | MNDR-E-MI-01211 |
MNDR | hsa-let-7d-5p | Oral squamous cell carcinoma | MNDR-E-MI-01212 |
MNDR | hsa-let-7d-5p | Lymphoma | MNDR-E-MI-01213 |
MNDR | hsa-let-7d-5p | Lymphoma non-hodgkin | MNDR-E-MI-01214 |
MNDR | hsa-let-7d-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-01215 |
MNDR | hsa-let-7d-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-01216 |
MNDR | hsa-let-7d-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-01217 |
MNDR | hsa-let-7d-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-01218 |
MNDR | hsa-let-7d-5p | Her2-receptor positive breast cancer | MNDR-E-MI-01219 |
MNDR | hsa-let-7d-5p | Breast cancer luminal | MNDR-E-MI-01220 |
MNDR | hsa-let-7d-5p | Prostate cancer | MNDR-E-MI-01221 |
MNDR | hsa-let-7d-5p | Gastric cancer | MNDR-E-MI-01222 |
MNDR | hsa-let-7d-5p | Gastric lymphoma | MNDR-E-MI-01223 |
MNDR | hsa-let-7d-5p | Alzheimer disease | MNDR-E-MI-01224 |
MNDR | hsa-let-7d-5p | Dysautonomia familial | MNDR-E-MI-01225 |
MNDR | hsa-let-7d-5p | Seizures | MNDR-E-MI-01226 |
MNDR | hsa-let-7d-5p | Cardiovascular disease | MNDR-E-MI-01227 |
MNDR | hsa-let-7d-5p | Carotid stenosis | MNDR-E-MI-01228 |
MNDR | hsa-let-7d-5p | Lung cancer | MNDR-E-MI-01229 |
MNDR | hsa-let-7d-5p | Metabolic syndrome x | MNDR-E-MI-01230 |
MNDR | hsa-let-7d-5p | Parkinson disease | MNDR-E-MI-01231 |
MNDR | hsa-let-7d-5p | Breast cancer | MNDR-E-MI-01232 |
MNDR | hsa-let-7d-5p | Pancreatic cancer | MNDR-E-MI-01233 |
MNDR | hsa-let-7d-5p | Melanoma | MNDR-E-MI-01234 |
MNDR | hsa-let-7d-5p | Nephroblastoma | MNDR-E-MI-01235 |
MNDR | hsa-let-7d-5p | Colon cancer | MNDR-E-MI-01236 |
MNDR | hsa-let-7d-5p | Ischemic attack transient | MNDR-E-MI-01237 |
MNDR | hsa-let-7d-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-01238 |
MNDR | hsa-let-7d-5p | Familial ovarian cancer | MNDR-E-MI-01239 |
MNDR | hsa-let-7d-5p | Prostate adenocarcinoma | MNDR-E-MI-01240 |
MNDR | hsa-let-7d-5p | Carcinoma ductal breast | MNDR-E-MI-01241 |
MNDR | hsa-let-7d-5p | Glioblastoma | MNDR-E-MI-01242 |
MNDR | hsa-let-7d-5p | Glioma | MNDR-E-MI-01243 |
MNDR | hsa-let-7d-5p | Chordoma | MNDR-E-MI-01244 |
MNDR | hsa-let-7d-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-01245 |
MNDR | hsa-let-7d-5p | Osteosarcoma | MNDR-E-MI-01246 |
MNDR | hsa-let-7d-5p | Liposarcoma | MNDR-E-MI-01247 |
MNDR | hsa-let-7d-5p | Meningioma | MNDR-E-MI-01248 |
MNDR | hsa-let-7d-5p | Liver cancer | MNDR-E-MI-01249 |
MNDR | hsa-let-7d-5p | Uterine cancer | MNDR-E-MI-01250 |
MNDR | hsa-let-7d-5p | Cervical adenocarcinoma | MNDR-E-MI-01251 |
MNDR | hsa-let-7d-5p | Lung squamous cell carcinoma | MNDR-E-MI-01252 |
MNDR | hsa-let-7d-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-01253 |
MNDR | hsa-let-7d-5p | Lung adenocarcinoma | MNDR-E-MI-01254 |
MNDR | hsa-let-7d-5p | Adrenocortical cancer | MNDR-E-MI-01255 |
MNDR | hsa-let-7d-5p | Thyroid carcinoma | MNDR-E-MI-01256 |
MNDR | hsa-let-7d-5p | Tuberculosis | MNDR-E-MI-01257 |
MNDR | hsa-let-7d-5p | Bladder urothelial carcinoma | MNDR-E-MI-01258 |
MNDR | hsa-let-7d-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-01259 |
MNDR | hsa-let-7d-5p | Renal clear cell carcinoma | MNDR-E-MI-01260 |
MNDR | hsa-let-7d-5p | Biliary tract cancer | MNDR-E-MI-01261 |
MNDR | hsa-let-7d-5p | Cholangiocarcinoma | MNDR-E-MI-01262 |
MNDR | hsa-let-7d-5p | Esophageal cancer | MNDR-E-MI-01263 |
MNDR | hsa-let-7d-5p | Lung small cell carcinoma | MNDR-E-MI-01264 |
MNDR | hsa-let-7d-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-01265 |
MNDR | hsa-let-7d-5p | Fibromyalgia | MNDR-E-MI-01266 |
MNDR | hsa-let-7d-5p | Adenoma | MNDR-E-MI-01267 |
MNDR | hsa-let-7d-5p | Breast invasive carcinoma | MNDR-E-MI-01268 |
MNDR | hsa-let-7d-5p | Early hepatocellular carcinoma | MNDR-E-MI-01269 |
MNDR | hsa-let-7d-5p | Familiar ovarian carcinoma | MNDR-E-MI-01270 |
MNDR | hsa-let-7d-5p | B-cell lymphoma | MNDR-E-MI-01271 |
MNDR | hsa-let-7d-5p | Rheumatoid arthritis | MNDR-E-MI-01272 |
MNDR | hsa-let-7d-5p | T-cell leukemia | MNDR-E-MI-01273 |
MNDR | hsa-let-7d-5p | Retinoblastoma | MNDR-E-MI-01274 |
MNDR | hsa-let-7d-5p | Neuroblastoma | MNDR-E-MI-01275 |
MNDR | hsa-let-7d-5p | Hodgkin lymphoma | MNDR-E-MI-01276 |
MNDR | hsa-let-7d-5p | Burkitt lymphoma | MNDR-E-MI-01277 |
MNDR | hsa-let-7d-5p | Tonsil cancer | MNDR-E-MI-01278 |
MNDR | hsa-let-7d-5p | Acute myelocytic leukemia | MNDR-E-MI-01279 |
MNDR | hsa-let-7d-5p | Colorectal cancer | MNDR-E-MI-01280 |
MNDR | hsa-let-7d-5p | Nasopharynx carcinoma | MNDR-E-MI-01281 |
MNDR | hsa-let-7d-5p | Multiple myeloma | MNDR-E-MI-01282 |
MNDR | hsa-let-7d-5p | Nasopharyngeal cancer | MNDR-E-MI-01283 |
MNDR | hsa-let-7d-5p | Prostatic neoplasms | MNDR-E-MI-01284 |
MNDR | hsa-let-7d-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-01285 |
MNDR | hsa-let-7d-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-01286 |
MNDR | hsa-let-7d-5p | Breast cancer her3+ negative | MNDR-E-MI-01287 |
MNDR | hsa-let-7d-5p | High grade dysplastic nodule | MNDR-E-MI-01288 |
MNDR | hsa-let-7d-5p | Tubulovillous adenoma | MNDR-E-MI-01289 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABT1 | Homo sapiens | RR00027895 |
TOP